These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17051347)

  • 1. A revised method of troponin exchange in permeabilised cardiac trabeculae using vanadate: functional consequences of a HCM-causing mutation in troponin I.
    Preston LC; Watkins H; Redwood CS
    J Muscle Res Cell Motil; 2006; 27(8):585-90. PubMed ID: 17051347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
    Gomes AV; Harada K; Potter JD
    J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced troponin I binding explains the functional changes produced by the hypertrophic cardiomyopathy mutation A8V of cardiac troponin C.
    Zot HG; Hasbun JE; Michell CA; Landim-Vieira M; Pinto JR
    Arch Biochem Biophys; 2016 Jul; 601():97-104. PubMed ID: 26976709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.
    Burton D; Abdulrazzak H; Knott A; Elliott K; Redwood C; Watkins H; Marston S; Ashley C
    Biochem J; 2002 Mar; 362(Pt 2):443-51. PubMed ID: 11853553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of troponin T mutations in familial hypertrophic cardiomyopathy on regulatory functions of other troponin subunits.
    Takahashi-Yanaga F; Ohtsuki I; Morimoto S
    J Biochem; 2001 Jul; 130(1):127-31. PubMed ID: 11432788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice.
    Wen Y; Pinto JR; Gomes AV; Xu Y; Wang Y; Wang Y; Potter JD; Kerrick WG
    J Biol Chem; 2008 Jul; 283(29):20484-94. PubMed ID: 18430738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of skinned cardiac fibres with human recombinant cardiac troponin-I mutants and troponin-C.
    Dohet C; al-Hillawi E; Trayer IP; Rüegg JC
    FEBS Lett; 1995 Dec; 377(2):131-4. PubMed ID: 8543035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of Myofilament-Localized Calcium Dynamics in Adult Cardiomyocytes and the Effect of Hypertrophic Cardiomyopathy Mutations.
    Sparrow AJ; Sievert K; Patel S; Chang YF; Broyles CN; Brook FA; Watkins H; Geeves MA; Redwood CS; Robinson P; Daniels MJ
    Circ Res; 2019 Apr; 124(8):1228-1239. PubMed ID: 30732532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.
    Bayliss CR; Jacques AM; Leung MC; Ward DG; Redwood CS; Gallon CE; Copeland O; McKenna WJ; Dos Remedios C; Marston SB; Messer AE
    Cardiovasc Res; 2013 Mar; 97(3):500-8. PubMed ID: 23097574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR and mutagenesis studies on the phosphorylation region of human cardiac troponin I.
    Ward DG; Brewer SM; Gallon CE; Gao Y; Levine BA; Trayer IP
    Biochemistry; 2004 May; 43(19):5772-81. PubMed ID: 15134451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
    Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A switch that lowers the betaAR: insights from a troponin I mutation linked to hypertrophic cardiomyopathy.
    Westfall MV
    J Mol Cell Cardiol; 2006 Jan; 40(1):10-2. PubMed ID: 16321398
    [No Abstract]   [Full Text] [Related]  

  • 13. Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy.
    James J; Zhang Y; Osinska H; Sanbe A; Klevitsky R; Hewett TE; Robbins J
    Circ Res; 2000 Oct; 87(9):805-11. PubMed ID: 11055985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troponin I phosphorylation does not increase the rate of relaxation following laser flash photolysis of diazo-2 in guinea-pig skinned trabeculae.
    Johns EC; Simnett SJ; Mulligan IP; Ashley CC
    Pflugers Arch; 1997 Apr; 433(6):842-4. PubMed ID: 9049178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential protein expression profiling of myocardial tissue in a mouse model of hypertrophic cardiomyopathy.
    Lam L; Tsoutsman T; Arthur J; Semsarian C
    J Mol Cell Cardiol; 2010 May; 48(5):1014-22. PubMed ID: 19715700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troponin replacement in permeabilized cardiac muscle. Reversible extraction of troponin I by incubation with vanadate.
    Strauss JD; Zeugner C; Van Eyk JE; Bletz C; Troschka M; Rüegg JC
    FEBS Lett; 1992 Oct; 310(3):229-34. PubMed ID: 1397278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.
    Doolan A; Tebo M; Ingles J; Nguyen L; Tsoutsman T; Lam L; Chiu C; Chung J; Weintraub RG; Semsarian C
    J Mol Cell Cardiol; 2005 Feb; 38(2):387-93. PubMed ID: 15698845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The muscle-relaxing C-terminal peptide from troponin I populates a nascent helix, facilitating binding to tropomyosin with a potent therapeutic effect.
    Hornos F; Feng HZ; Rizzuti B; Palomino-Schätzlein M; Wieczorek D; Neira JL; Jin JP
    J Biol Chem; 2021; 296():100228. PubMed ID: 33814345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.
    Sorajja P; Elliott PM; McKenna WJ
    Europace; 2000 Jan; 2(1):4-14. PubMed ID: 11225594
    [No Abstract]   [Full Text] [Related]  

  • 20. Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy-Associated Mutation in Human Cardiac Troponin I (K206I).
    Warren CM; Karam CN; Wolska BM; Kobayashi T; de Tombe PP; Arteaga GM; Bos JM; Ackerman MJ; Solaro RJ
    Circ Cardiovasc Genet; 2015 Dec; 8(6):765-73. PubMed ID: 26553696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.